🧪 New compounds tackle cancer and infections
Chemists have successfully developed dual-action compounds targeting both cancer and infections. This research was conducted by a team of scientists at a major research institute. The compounds showed promising results in lab tests conducted on October 15, 2023. These molecules operate by attacking multiple pathways simultaneously, increasing treatment effectiveness. Further clinical trials are planned to test the safety and efficacy of these new drugs. 🧪